Meanwhile, we compared CIN III and CC groups and found significant differences in HSP90AA1, ICAM1, EZH2, ARG2, and macrophage M1, indicating these may be biomarkers for predicting CIN III’s progression to CC. This evidence concerns the gene HSP90AA1 and uterine cervix carcinoma in situ.